Challenges Facing the Pharmaceutical Industry
The webinar "Challenges Facing the Pharmaceutical Industry" organized by ChemistryViews.org will take place on Thursday March 27, 2014 at 8:00 PDT | 11:00 EDT | 15:00 UK | 16:00 CET.
John LaMattina, former President, Pfizer Global R&D, discusses how and why the pharma industry is devalued and distrusted.
Topics covered in the webinar are:
a) Challenges facing the industry: establishing the safety AND value of new drugs;
b) Issues facing the Industry on its reputation;
c) A prescription form restoring its reputation.
John La Mattina is a Senior Partner at PureTech Health and author of the books:
Drug Truths: Dispelling the Myths About Pharma R&D and Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?
Please follow this link to register for the webinar.
most read
Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Ratcliffe: Chemical Industry in Europe at a Tipping Point
Ineos CEO Ineos calls on European politicians to save the chemical industry.
CHEManager International Media Kit 2026
Compelling solutions through strategic partnerships
Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.